abstract |
The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof: (I) Wherein R 1 , R 2 , R 3 and R 4 are as defined herein. It also relates to methods of making the compounds and methods of using the compounds for the treatment of diseases associated with calcium release-activated calcium channels (CRACs). |